Dpyd Genotyping

DPYD Genotyping is a pharmacogenetic testing method that identifies genetic variants in the *DPYD* gene responsible for dihydropyrimidine dehydrogenase enzyme activity, enabling the prediction of individual susceptibility to severe toxicity from fluoropyrimidine chemotherapy.

147

Publications

8.2K

Citations

1.2K

Authors

454

Institutions

Publications per year

2017–2026

76

Authors

1.2K

  1. JH
    Jan H.M. Schellens

    The Netherlands Cancer Institute, Netherlands

    15 publications · 1.5K citations

    14

    h-index

  2. AB
    André B. P. Kuilenburg

    University of Amsterdam, Netherlands

    13 publications · 1.2K citations

    13

    h-index

  3. AC
    Annemieke Cats

    The Netherlands Cancer Institute, Netherlands

    13 publications · 1.5K citations

    12

    h-index

  4. LM
    Linda M. Henricks

    The Netherlands Cancer Institute, Netherlands

    11 publications · 960 citations

    11

    h-index

  5. JH
    Jos H. Beijnen

    The Netherlands Cancer Institute, Netherlands

    11 publications · 1.4K citations

    10

    h-index

1–5 of 1.2K

Venues

  1. Pharmacogenomics

    9 publications · 348 citations

    9

    h-index

  2. PubMed

    Repository · 8 publications · 329 citations

    8

    h-index

  3. Cancer Chemotherapy and Pharmacology

    8 publications · 173 citations

    8

    h-index

  4. British Journal of Cancer

    BJC · 6 publications · 421 citations

    6

    h-index

  5. Clinical Cancer Research

    5 publications · 523 citations

    5

    h-index

1–5